Abstract
Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Current Pharmaceutical Design
Title:Novel Insights into Vascular Repair Mechanisms
Volume: 20 Issue: 14
Author(s): Nicolle Krankel, Thomas F. Luscher and Ulf Landmesser
Affiliation:
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Abstract: Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Export Options
About this article
Cite this article as:
Krankel Nicolle, Luscher F. Thomas and Landmesser Ulf, Novel Insights into Vascular Repair Mechanisms, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113199990478
| DOI https://dx.doi.org/10.2174/13816128113199990478 |
Print ISSN 1381-6128 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Multidisciplinary Pharmaceutical Drug Design Strategies in the Progress of Drug Discovery"
The process of developing a drug is time and money-consuming, but also fascinating. The development of numerous computational techniques, synthetic methodologies, formulation-based drug discovery, etc., has improved the drug discovery process. The process of developing new drugs is significantly hampered by drug-poor pharmacodynamics and pharmacokinetic problems. To address these challenges, ...read more
Accelerating Cancer drug discovery using Artificial intelligence and In Silico methods
The Artificial intelligence and in silico methods speed up cancer drug discovery, transforming how new treatments are developed. Artificial intelligence, along with in silico methods, allows for quick investigation of large biological datasets, helping identify potential drug targets with remarkable speed and accuracy. Machine learning models help us understand how ...read more
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Artificial Intelligence and Computational Approaches in Drug Discovery
Computer-aided drug design (CADD) and artificial intelligence (AI) are fundamentally reshaping drug discovery pipelines by significantly enhancing efficiency in molecular screening, rational drug design, and natural product development. In the field of molecular screening, the integration of virtual high-throughput screening with advanced AI models enables rapid analysis of million-compound libraries, ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Anti-Cancer Agents in Medicinal Chemistry Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma
Current Drug Targets Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets Inhibition of RET Activated Pathways: Novel Strategies for Therapeutic Intervention in Human Cancers
Current Pharmaceutical Design Clinical Next Generation Sequencing for Precision Medicine in Cancer
Current Genomics Transmembrane Interactions of HIV-1 Vpu and Tetherin
Current HIV Research Delineating Characteristic Sequence and Structural Features of Precursor and Mature Piwi-interacting RNAs of Epithelial Ovarian Cancer
Current Bioinformatics Effects of Highly Active Antiretroviral Therapy on HIV-1-Associated Oral Complications
Current HIV Research WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Anti-Cancer Agents in Medicinal Chemistry New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis
Current Proteomics Design of multifunctional nanocarriers for delivery of anti-cancer therapy
Current Pharmaceutical Design Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Recent Advances of MEK Inhibitors and Their Clinical Progress
Current Topics in Medicinal Chemistry Cardiac Toxicity of Antineoplastic Anthracyclines
Current Medicinal Chemistry - Anti-Cancer Agents Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design Solenostemma argel: A Rich Source of Very Unusual Pregnane and 14,15- Secopregnane Glycosides with Antiproliferative Activity
Current Organic Chemistry Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer
Current Cancer Therapy Reviews The Effects of Vitamin C on Adriamycin-Induced Hypercholesterolemia in Rat
Current Nutrition & Food Science





